PACTR202204600690227尚未招募2 期
COMPASSIONATE COVID-19 TREATMENT PROJECT INTENDED TO EVALUATE SAFETY AND EFFICACY OF THE NIMRCAF, COVIDOL AND BUPIJI OIL – THE HERBAL PREPARATIONS FOR THE TREATMENT OF COVID-19 PATIENTS
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 416
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •Confirmed COVID-19 patients aged eighteen years and above
- •Hospitalized and with moderate or severe form of disease, during the study period at any of the study sites
- •Consented participant
排除标准
- •Unconsented participant
- •Patient with any clinically significant Grade 3 or 4 laboratory abnormality according to the Division of AIDS (DAIDS) grading scale
- •Patient aged less than eighteen years
- •Patient with peptic ulcers
- •History of using any of the investigational herbal preparations
- •Pregnant women
- •COVID-19 patients with mild signs and symptoms
研究者
相似试验
尚未招募
不适用
Ozone Therapy for Covid 19 patientsCTRI/2020/07/026671Bisleri charitable trust
招募中
不适用
Post-COVID-19-Treatment StudyU09.9Post COVID-19 condition, unspecifiedDRKS00033476Johannes Gutenberg-Universität Mainz, Abteilung für Klinische Psychologie, Psychotherapie und Experimentelle Psychotherapie zusammen mit der Hochschulambulanz für Forschung und Lehre der Poliklinischen Institutsambulanz für Psychotherapie54
进行中（未招募）
不适用
Acupuncture treatment of people with residual symptoms of COVID-19 infectioSequelae of other specified infectious and parasitic diseasesB34.2RBR-29bt5qtHospital do Servidor Público Municipal
终止
3 期
CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)COVID-19NCT04348656Hamilton Health Sciences Corporation940
进行中（未招募）
1 期
Treatments of COVID-19 in primary care in the NetherlandsPatients with symptomatic COVID-19 in the community and in primary care, who are at higher risk of a complicated illness course.MedDRA version: 23.0Level: PTClassification code: 10084268Term: COVID-19 Class: 100000004862CTIS2022-501559-99-00Maastricht University682